B
Regeneron Pharmaceuticals, Inc. REGN
$828.42 $3.940.48%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 13.30B 12.92B 12.56B 12.58B 12.65B
Total Other Revenue 548.10M 572.20M 537.00M 536.10M 451.30M
Total Revenue 13.85B 13.49B 13.10B 13.12B 13.10B
Cost of Revenue 5.74B 5.49B 5.40B 5.28B 5.17B
Gross Profit 8.11B 8.00B 7.70B 7.84B 7.93B
SG&A Expenses 2.90B 2.83B 2.72B 2.63B 2.55B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 37.40M 28.90M 13.70M -2.10M -8.20M
Total Operating Expenses 9.76B 9.42B 9.11B 8.88B 8.69B
Operating Income 4.09B 4.07B 3.99B 4.23B 4.41B
Income Before Tax 4.97B 4.59B 4.04B 4.20B 4.38B
Income Tax Expenses 314.90M 265.50M 184.20M 245.70M 385.30M
Earnings from Continuing Operations 4.65K 4.32K 3.86K 3.95K 3.99K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 4.65B 4.32B 3.86B 3.95B 3.99B
EBIT 4.09B 4.07B 3.99B 4.23B 4.41B
EBITDA 4.56B 4.52B 4.42B 4.65B 4.82B
EPS Basic 43.23 40.31 36.11 37.05 37.36
Normalized Basic EPS 27.35 27.05 26.28 27.24 28.12
EPS Diluted 40.41 37.76 33.85 34.75 35.05
Normalized Diluted EPS 25.57 25.35 24.64 25.56 26.40
Average Basic Shares Outstanding 430.60M 428.80M 427.70M 427.00M 427.40M
Average Diluted Shares Outstanding 460.50M 457.70M 456.20M 455.10M 455.30M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings